| Literature DB >> 26388854 |
Yaowen Chang1, Guangxin Luan2, Ying Xu3, Yanhong Wang2, Min Shen2, Chi Zhang1, Wei Zheng1, Jinwei Huang4, Jingni Yang2, Xu Jia2, Baodong Ling1.
Abstract
Carbapenem-resistant Acinetobacter baumannii (CRAB) presents a serious therapeutic and infection control challenge. In this study, we investigated the epidemiological and molecular differences of CRAB and the threatening factors for contributing to increased CRAB infections at a hospital in western China. A total of 110 clinical isolates of A. baumannii, collected in a recent 2-year period, were tested for carbapenem antibiotic susceptibility, followed by a molecular analysis of carbapenemase genes. Genetic relatedness of the isolates was characterized by multilocus sequence typing. Sixty-seven of the 110 isolates (60.9%) were resistant to carbapenems, 80.60% (54/67) of which carried the bla OXA-23 gene. Most of these CRAB isolates (77.62%) were classified as clone complex 92 (CC92), and sequence type (ST) 92 was the most prevalent STs, followed by ST195, ST136, ST843, and ST75. One CRAB isolate of ST195 harbored plasmid pAB52 from a Chinese patient without travel history. This plasmid contains toxin-antitoxin elements related to adaptation for growth, which might have emerged as a common vehicle indirectly mediating the spread of OXA-23 in CRAB. Thus, CC92 A. baumannii carrying OXA-23 is a major drug-resistant strain spreading in China. Our findings indicate that rational application of antibiotics is indispensable for minimizing widespread of drug resistance.Entities:
Keywords: Acinetobacter baumannii; CC92; OXA-23; carbapenem resistance; plasmid
Year: 2015 PMID: 26388854 PMCID: PMC4555021 DOI: 10.3389/fmicb.2015.00910
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Primers used in this study.
| Locus | Primer | Oligonucleotides (5′→ 3′) | Expected size (bp) | Source |
|---|---|---|---|---|
| 16S | F | CAT TAT CAC GGT AAT TAG TG | 208 | |
| R | AGA GCA CTG TGC ACT TAA G | |||
| RecA | F | CCT GAA TCT TCT GGT AAA AC | 425 | |
| R | GTT TCT GGG CTG CCA AAC ATT AC | |||
| KPC | F | GCT CAG GCG CAA CTG TAA GT | 823 | |
| R | GTC CAG ACG GAA CGT GGT AT | |||
| IMP | F | CTA CCG CAG AGT CTT TG | 587 | |
| R | AAC CAG TTT TGC CTT ACC AT | |||
| VIM-1 | F | AGT GGT GAG TAT CCG ACA G | 261 | |
| R | ATG AAA GTG CGT GGA GAC | |||
| 17SIM | F | TAC AAG GGA TTC GGC ATC G | 570 | |
| R | TAA TGG CCT GTT CCC ATG TG | |||
| NDM-1 | F | TCT CGA CAT GCC GGG TTT CGG | 475 | |
| R | ACC GAG ATT GCC GAG CGA CTT | |||
| AmpC | F | ACT TAC TTC AAC TCG CGA CG | 663 | |
| R | TAA ACA CCA CAT ATG TTC CG | |||
| OXA-23 | F | GAT CGG ATT GGA GAA CCA GA | 501 | |
| R | ATT TCT GAC CGC ATT TCC AT | |||
| OXA-24 | F | CAA GAG CTT GCA AGA CGG ACT | 420 | |
| R | TCC AAG ATT TTC TAG CRA CTT ATA | |||
| OXA-51 | F | TAA TGC TTT GAT CGG CCT TG | 353 | |
| R | TGG ATT GCA CTT CAT CTT GG | |||
| OXA-58 | F | TCG ATC AGA ATG TTC AAG CGC | 530 | |
| R | ACG ATT CTC CCC TCT GCG C | |||
| OXA-235 | F | TTG TTG CCT TTA CTT AGT TGC | 831 | |
| R | CAA AAT TTT AAG ACG GAT CG |
Clinical characteristics of 67 patients with Carbapenem-resistant Acinetobacter baumannii (CRAB).
| Gender | Total number | Source | Total number | Department | Total number |
|---|---|---|---|---|---|
| Male | 40 (59.70%) | Blood | 1 (1.49%) | Intensive care unit | 24 (35.82%) |
| Female | 27 (40.30%) | Sputum | 49 (73.13%) | Respiratory | 17 (25.37%) |
| Swab | 5 (7.46%) | Neurosurgery | 9 (13.43%) | ||
| 0–20 | 1 | Secretion | 5 (7.46%) | Infectious diseases department | 2 (2.99%) |
| 21–50 | 11 | Douche | 4 (5.98%) | Other wards | 15 (22.39%) |
| 51–60 | 13 | Cerebrospinal fluid | 2 (2.99%) | ||
| 70–more | 27 | Other | 2 (2.99%) |
Positive rates of β-lactamase genes in CRAB.
| No. of strains | Rate of gene (%) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KPC | IMP | VIM-1 | SIM | NDM-1 | AmpC | OXA-23 | OXA-24 | OXA-51 | OXA-58 | OXA-235 | |
| 67 | 0 | 0 | 0 | 0 | 0 | 97.10 | 80.60 | 0 | 100 | 0 | 0 |